For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party with a Purpose, a Philadelphia gala that raises funds for cancer …
Read More
Cancer cells ingest copious amounts of the simple sugar glucose. This addiction may hold the key to how cancer can be treated.
Read More
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to treat 10 different types of cancer, in addition to solid tumors located anywhere in the body that have certain DNA damage and repair-related biomarkers. However, only a small percentage of patients respond to these treatments, and they can have significant side effects. Researchers are looking for biomarkers that can identify patients who are likely to respond to immune checkpoint inhibitors.
Read More
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving career his native Nigeria, studying African ethnomedicine in the management, prevention, and control of cancer and diabetes.
Read MoreScientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well a drug targets a disease, the majority of this research is funded by the National Institutes of Health (NIH). So, on September 14, 2017, hundreds of people from 37 states and Washington, D.C., from over 300 institutes and organizations, gathered for the 5th Annual Rally for Medical Research with a common message
Read More
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just days before the start of breast cancer awareness month when it added a new molecularly targeted therapeutic to the armamentarium for oncologists treating patients with breast cancer: abemaciclib (Verzenio).
Read MoreOn Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss the latest advances in the field at the American Association for Cancer Research four-day conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment.
Read More
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics known as checkpoint inhibitors are a treatment option when it expanded the approved uses of nivolumab (Opdivo) and pembrolizumab (Keytruda) to include certain patients with liver cancer and stomach cancer, respectively.
Read More
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino physician work force dropped from 135 to 105 physicians per 100,000, according to a study by the Center for the Study of Latino Health and Culture at the University of California, Los Angeles.
This decline is alarming. It means that the growing Latino population does not get culturally competent care needed to improve patient health outcomes.
Read More
After several previous attempts to repeal the Affordable Care Act (ACA) failed, another attempt is nearing a vote in the U.S. Senate.
Read More
The AACR is holding a special conference, Advances in Modeling Cancer in Mice: Technology, Biology, and Beyond, in Orlando, Florida, September 24-27. This conference will highlight recent advances in the design and implementation of genetically engineered mouse models of cancer.
Read More